SIEN News

GC Aesthetics, a provider of silicone breast implants in Latin America and EMEA, announced terms for its IPO on Monday. The Dublin, Ireland-based company plans to raise $75 million by offering 5.4 million shares at a price range of $13 to $15. At the midpoint of the proposed range, it would command a fully diluted market value of $260 million. GC Aesthetics, which was...read more

GC Aesthetics, a provider of silicone breast implants in Latin America and EMEA, filed on Wednesday with the SEC to raise up to $75 million in an initial public offering. The Dublin, Ireland-based company, which was founded in 1979 and booked $55 million in sales for the 12 months ended March 31, 2015, plans to list on the NASDAQ. It has not selected a ticker symbol. GC...read more

Four IPOs raised $1.2 billion during the past week, the third week in a row with five or less. Year-to-date, the IPO market has seen 235 initial public offerings raise $75 billion. The week's energy, health care, finance and consumer IPOs saw moderate returns, led by the year's largest and best-performing MLP, Shell Midstream Partners LP, which upsized its $920 million offering and...read more

Sientra, the newest of the three sellers of breast implants in the US, raised $75 million by offering 5 million shares at $15, the midpoint of the range of $14 to $16. Sientra plans to list on the NASDAQ under the symbol SIEN. Sientra initially filed confidentially on 7/18/2014. Piper Jaffray and Stifel acted as lead managers on the deal....read more